K Pharma (TSE:4896) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is K Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. K Pharma's annualized Gross Profit for the quarter that ended in Mar. 2024 was 円0 Mil. K Pharma's average Total Assets over the quarter that ended in Mar. 2024 was 円3,143 Mil. Therefore, K Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.00%.

K Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for K Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

K Pharma Gross-Profit-to-Asset % Chart

K Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

38.82

K Pharma Quarterly Data
	Dec21	Dec22	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of K Pharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, K Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

K Pharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, K Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where K Pharma's Gross-Profit-to-Asset % falls into.

K Pharma Gross-Profit-to-Asset % Calculation

K Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	910	/	( (1374.566	+	3313.902)	/ 2 )
	=	910	/	2344.234
	=	38.82 %

K Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	0	/	( (3313.902	+	2972.056)	/ 2 )
	=	0	/	3142.979
	=	0.00 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

K Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of K Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

K Pharma (TSE:4896) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » K Pharma Inc (TSE:4896) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

7-7-7 Roppongi, Minato-ku, Tokyo, JPN, 106-0032

Website

https://en.kpharma.co.jp

K Pharma Inc is a company involved in Research, development, manufacturing, sales and marketing of pharmaceutical products and regenerative medicine products. It is involved in studying of iPs cells in regnerative medecine to treat neurological conditions such as cerebral infarction and SCI.

K Pharma (TSE:4896) Headlines

No Headlines